Portage Biotech Stock Buy Hold or Sell Recommendation
| PRTG Stock | USD 4.21 0.17 4.21% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Portage Biotech is 'Strong Sell'. Macroaxis provides Portage Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRTG positions.
Check out Portage Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide. Note, we conduct extensive research on individual companies such as Portage and provide practical buy, sell, or hold advice based on investors' constraints. Portage Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Portage |
Execute Portage Biotech Buy or Sell Advice
The Portage recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Portage Biotech. Macroaxis does not own or have any residual interests in Portage Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Portage Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Portage Biotech Trading Alerts and Improvement Suggestions
| Portage Biotech is way too risky over 90 days horizon | |
| Portage Biotech appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Portage Biotech currently holds about 21.18 M in cash with (14.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
| Roughly 51.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial |
Portage Biotech Returns Distribution Density
The distribution of Portage Biotech's historical returns is an attempt to chart the uncertainty of Portage Biotech's future price movements. The chart of the probability distribution of Portage Biotech daily returns describes the distribution of returns around its average expected value. We use Portage Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Portage Biotech returns is essential to provide solid investment advice for Portage Biotech.
| Mean Return | 1.43 | Value At Risk | -10.11 | Potential Upside | 8.33 | Standard Deviation | 23.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Portage Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Portage Stock Institutional Investors
| Shares | Princeton Global Asset Management Llc | 2024-12-31 | 8.0 | Bnp Paribas Arbitrage, Sa | 2024-12-31 | 7.0 | Connective Capital Management Llc | 2024-12-31 | 0.0 | The Toronto-dominion Bank | 2024-09-30 | 0.0 | Carolinas Wealth Consulting Llc | 2024-09-30 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | Virtu Financial Llc | 2024-12-31 | 0.0 | Ieq Capital, Llc | 2024-09-30 | 0.0 | Lakeview Capital Partners, Llc | 2024-12-31 | 19.3 K | Citadel Advisors Llc | 2024-12-31 | 15.4 K |
Portage Biotech Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (382K) | 20.6M | (12.8M) | (5.5M) | (6.3M) | (6.0M) | |
| Free Cash Flow | (3.3M) | (6.8M) | (12.1M) | (14.3M) | (12.9M) | (12.2M) | |
| Other Non Cash Items | 1.4M | (670K) | 106.2M | 67.9M | 78.1M | 82.0M | |
| Net Income | (17.2M) | (19.2M) | (104.7M) | (75.3M) | (67.8M) | (64.4M) | |
| End Period Cash Flow | 2.8M | 23.4M | 10.5M | 5.0M | 5.8M | 3.2M | |
| Net Borrowings | (50K) | 700K | (2.0M) | (2M) | (1.8M) | (1.7M) | |
| Change To Netincome | 1.5M | 12.2M | 10.6M | 92.5M | 106.4M | 111.8M |
Portage Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Portage Biotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Portage Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Portage stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.49 | |
β | Beta against Dow Jones | -8.56 | |
σ | Overall volatility | 23.83 | |
Ir | Information ratio | 0.07 |
Portage Biotech Volatility Alert
Portage Biotech is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Portage Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Portage Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Portage Biotech Fundamentals Vs Peers
Comparing Portage Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Portage Biotech's direct or indirect competition across all of the common fundamentals between Portage Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Portage Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Portage Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Portage Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Portage Biotech to competition |
| Fundamentals | Portage Biotech | Peer Average |
| Return On Equity | -1.99 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Current Valuation | 5.19 M | 16.62 B |
| Shares Outstanding | 1.65 M | 571.82 M |
| Shares Owned By Insiders | 51.37 % | 10.09 % |
| Shares Owned By Institutions | 6.19 % | 39.21 % |
| Number Of Shares Shorted | 13.03 K | 4.71 M |
| Price To Book | 4.96 X | 9.51 X |
| EBITDA | (18.2 M) | 3.9 B |
| Net Income | (75.34 M) | 570.98 M |
| Cash And Equivalents | 21.18 M | 2.7 B |
| Cash Per Share | 1.25 X | 5.01 X |
| Total Debt | 47 K | 5.32 B |
| Current Ratio | 11.73 X | 2.16 X |
| Book Value Per Share | 1.25 X | 1.93 K |
| Cash Flow From Operations | (14.3 M) | 971.22 M |
| Short Ratio | 0.16 X | 4.00 X |
| Earnings Per Share | (68.17) X | 3.12 X |
| Target Price | 140.0 | |
| Number Of Employees | 7 | 18.84 K |
| Beta | 1.61 | -0.15 |
| Market Capitalization | 6.93 M | 19.03 B |
| Total Asset | 7.78 M | 29.47 B |
| Retained Earnings | (239.32 M) | 9.33 B |
| Working Capital | 4.82 M | 1.48 B |
| Net Asset | 7.78 M |
Portage Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Portage . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Portage Biotech Buy or Sell Advice
When is the right time to buy or sell Portage Biotech? Buying financial instruments such as Portage Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Portage Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Volatility ETFs Thematic Idea Now
Volatility ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Portage Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.